Stocks News

LAST PRICE
55.6800
TODAY'S CHANGE (%)
Trending Up0.1400 (0.2521%)

Bid / Lots
55.3400/ 1
Ask / Lots
56.1700/ 1
Open / Previous Close
55.7800 / 55.5400
Day Range
Low 54.7300
High 56.8200
52 Week Range
Low 20.9600
High 62.5800
Volume
456,102
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Nov 5, 2024
- Agios to Present New Data on Mitapivat and Tebapivat in Rare Blood Disorders at 66th ASH Annual Meeting and Exposition, from 9:05AM ET on Tuesday Nov 05, 2024 by Dow Jones
  9:05AM ET on Tuesday Nov 05, 2024 by Dow Jones
  Companies Mentioned: AGIO
  
  whether as a result of new information, future events or otherwise, except as required by law.
  
  Contacts:
  
  Investor Contact
  
  Chris Taylor, VP, Investor Relations and Corporate Communications
Nov 1, 2024
- DJ Agios Pharmaceuticals Price Target Maintained With a $55.00/Share by RBC Capital, from 12:43PM ET on Friday Nov 01, 2024 by Dow Jones
  12:43PM ET on Friday Nov 01, 2024 by Dow Jones
  Companies Mentioned: AGIO
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/AGIO/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 01, 2024 12:43 ET (16:43 GMT)
- DJ Agios Pharmaceuticals Is Maintained at Sector Outperform by Scotiabank, from 10:30AM ET on Friday Nov 01, 2024 by Dow Jones
  10:30AM ET on Friday Nov 01, 2024 by Dow Jones
  Companies Mentioned: AGIO
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/AGIO/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 01, 2024 10:30 ET (14:30 GMT)
Oct 31, 2024
- Agios Pharmaceuticals Shares Fall After Q3 Revenue Miss, from 10:34AM ET on Thursday Oct 31, 2024 by MT Newswires
  10:34AM ET on Thursday Oct 31, 2024 by MT Newswires
  Companies Mentioned: AGIO
  10:34 AM EDT, 10/31/2024 (MT Newswires) -- Agios Pharmaceuticals (AGIO) shares fell 2.7% in recent Thursday trading after the company's Q3 revenue fell below market expectations. The biopharmaceutical company reported Q3 net income Thursday of $16.2...
- -- Earnings Flash (AGIO) AGIOS PHARMACEUTICALS Reports Q3 Revenue $9.0M, from 6:30AM ET on Thursday Oct 31, 2024 by MT Newswires
  6:30AM ET on Thursday Oct 31, 2024 by MT Newswires
  Companies Mentioned: AGIO
  06:30 AM EDT, 10/31/2024 (MT Newswires) -- ...

Today
- DJ Edgewise Therapeutics Initiated at Outperform by Evercore ISI Group, from 13 hours ago by Dow Jones
  13 hours ago by Dow Jones
  Companies Mentioned: EWTX
Yesterday
- DJ Merus Initiated at Buy by Goldman Sachs, from 6:13AM ET on Thursday Nov 21, 2024 by Dow Jones
  6:13AM ET on Thursday Nov 21, 2024 by Dow Jones
  Companies Mentioned: MRUS
Nov 20, 2024
- DJ Merus Price Target Maintained With a $85.00/Share by Needham, from 7:07AM ET on Wednesday Nov 20, 2024 by Dow Jones
  7:07AM ET on Wednesday Nov 20, 2024 by Dow Jones
  Companies Mentioned: MRUS
Nov 19, 2024
- European Equities Traded in the US as American Depositary Decline Slightly in Tuesday Trading, from 11:18AM ET on Tuesday Nov 19, 2024 by MT Newswires
  11:18AM ET on Tuesday Nov 19, 2024 by MT Newswires
  Companies Mentioned: NTZ, PUK, NGG, SQNS, GRFS, VRNA, AMRN, AKTX, MREO, BNTX, SLN, CRTO, DBVT, ADAP, SAN, EDAP
- Verona Pharma Announces December 2024 Investor Conference Participation, from 2:00AM ET on Tuesday Nov 19, 2024 by Dow Jones
  2:00AM ET on Tuesday Nov 19, 2024 by Dow Jones
  Companies Mentioned: VRNA
Nov 13, 2024
- European Equities Traded in the US as American Depositary Fall in Wednesday Trading, from 10:59AM ET on Wednesday Nov 13, 2024 by MT Newswires
  10:59AM ET on Wednesday Nov 13, 2024 by MT Newswires
  Companies Mentioned: ING, NVO, PSO, SAP, TRIB, VOD, SQNS, GRFS, VRNA, AKTX, BCYC, BNTX, BCS, EVAX, TCBP, MTLS
Nov 8, 2024
- RBC Capital Adjusts Edgewise Therapeutics Price Target to $44 From $42, Maintains Outperform, Speculative Risk Rating, from 9:57AM ET on Friday Nov 08, 2024 by MT Newswires
  9:57AM ET on Friday Nov 08, 2024 by MT Newswires
  Companies Mentioned: EWTX
Nov 7, 2024
- European Equities Traded in the US as American Depositary Rise Thursday, from 11:25AM ET on Thursday Nov 07, 2024 by MT Newswires
  11:25AM ET on Thursday Nov 07, 2024 by MT Newswires
  Companies Mentioned: PHG, SAP, SQNS, VRNA, AUTL, OPRA, DAVA, AKTX, BCYC, MTLS, DBVT, CUK, ADAP, EDAP
- Edgewise Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights, from 8:00AM ET on Thursday Nov 07, 2024 by Dow Jones
  8:00AM ET on Thursday Nov 07, 2024 by Dow Jones
  Companies Mentioned: EWTX
- Press Release: Edgewise Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights, from 8:00AM ET on Thursday Nov 07, 2024 by Dow Jones
  8:00AM ET on Thursday Nov 07, 2024 by Dow Jones
  Companies Mentioned: EWTX

Agios Pharmaceuticals Inc
NASDAQ:AGIOUnited States

Search Criteria

Nov 5, 2024

Agios to Present New Data on Mitapivat and Tebapivat in Rare Blood Disorders at 66th ASH Annual Meeting and Exposition, from 9:05AM ET on Tuesday Nov 05, 2024 by Dow Jones

Nov 1, 2024

DJ Agios Pharmaceuticals Price Target Maintained With a $55.00/Share by RBC Capital, from 12:43PM ET on Friday Nov 01, 2024 by Dow Jones

DJ Agios Pharmaceuticals Is Maintained at Sector Outperform by Scotiabank, from 10:30AM ET on Friday Nov 01, 2024 by Dow Jones

Oct 31, 2024

Agios Pharmaceuticals Shares Fall After Q3 Revenue Miss, from 10:34AM ET on Thursday Oct 31, 2024 by MT Newswires

-- Earnings Flash (AGIO) AGIOS PHARMACEUTICALS Reports Q3 Revenue $9.0M, from 6:30AM ET on Thursday Oct 31, 2024 by MT Newswires

Peers Headlines

Today

DJ Edgewise Therapeutics Initiated at Outperform by Evercore ISI Group, from 13 hours ago by Dow Jones

Yesterday

DJ Merus Initiated at Buy by Goldman Sachs, from 6:13AM ET on Thursday Nov 21, 2024 by Dow Jones

Nov 20, 2024

DJ Merus Price Target Maintained With a $85.00/Share by Needham, from 7:07AM ET on Wednesday Nov 20, 2024 by Dow Jones

Nov 19, 2024

European Equities Traded in the US as American Depositary Decline Slightly in Tuesday Trading, from 11:18AM ET on Tuesday Nov 19, 2024 by MT Newswires

Verona Pharma Announces December 2024 Investor Conference Participation, from 2:00AM ET on Tuesday Nov 19, 2024 by Dow Jones

Nov 13, 2024

European Equities Traded in the US as American Depositary Fall in Wednesday Trading, from 10:59AM ET on Wednesday Nov 13, 2024 by MT Newswires

Nov 8, 2024

RBC Capital Adjusts Edgewise Therapeutics Price Target to $44 From $42, Maintains Outperform, Speculative Risk Rating, from 9:57AM ET on Friday Nov 08, 2024 by MT Newswires

Nov 7, 2024

European Equities Traded in the US as American Depositary Rise Thursday, from 11:25AM ET on Thursday Nov 07, 2024 by MT Newswires

Edgewise Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights, from 8:00AM ET on Thursday Nov 07, 2024 by Dow Jones

Press Release: Edgewise Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights, from 8:00AM ET on Thursday Nov 07, 2024 by Dow Jones